These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32781522)

  • 1. Involvement of p38 MAPK in Synaptic Function and Dysfunction.
    Falcicchia C; Tozzi F; Arancio O; Watterson DM; Origlia N
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
    Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
    J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease.
    Lee JK; Kim NJ
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
    Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
    Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease.
    Munoz L; Ammit AJ
    Neuropharmacology; 2010 Mar; 58(3):561-8. PubMed ID: 19951717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.
    Chen X; Lin R; Chang L; Xu S; Wei X; Zhang J; Wang C; Anwyl R; Wang Q
    Neuroscience; 2013 Dec; 253():435-43. PubMed ID: 24012839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation.
    Criscuolo C; Fabiani C; Bonadonna C; Origlia N; Domenici L
    Neurobiol Aging; 2015 Mar; 36(3):1303-9. PubMed ID: 25554494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 but not p38 MAP kinase is essential for the long-term depression in mouse cerebellar slices.
    Ito-Ishida A; Kakegawa W; Yuzaki M
    Eur J Neurosci; 2006 Sep; 24(6):1617-22. PubMed ID: 17004925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy.
    Kheiri G; Dolatshahi M; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Dec; 30(1):9-30. PubMed ID: 29804103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of ERK1/2 and p38 mitogen-activated protein kinases is dynamically regulated in the developing rat visual system.
    Oliveira CS; Rigon AP; Leal RB; Rossi FM
    Int J Dev Neurosci; 2008; 26(3-4):355-62. PubMed ID: 18280691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tea polyphenols and proanthocyanidins prevents menopause-related memory decline in rats via increased hippocampal synaptic plasticity by inhibiting p38 MAPK and TNF-α pathway.
    Yang Q; Zhang Y; Zhang L; Li X; Dong R; Song C; Cheng L; Shi M; Zhao H
    Nutr Neurosci; 2022 Sep; 25(9):1909-1927. PubMed ID: 33871312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP.
    Butler MP; O'Connor JJ; Moynagh PN
    Neuroscience; 2004; 124(2):319-26. PubMed ID: 14980382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Pannexin 1 Blockade Mitigates Early Synaptic Plasticity Defects in a Mouse Model of Alzheimer's Disease.
    Flores-Muñoz C; Gómez B; Mery E; Mujica P; Gajardo I; Córdova C; Lopez-Espíndola D; Durán-Aniotz C; Hetz C; Muñoz P; Gonzalez-Jamett AM; Ardiles ÁO
    Front Cell Neurosci; 2020; 14():46. PubMed ID: 32265655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MK2 cascade mediates transient alteration in mGluR-LTD and spatial learning in a murine model of Alzheimer's disease.
    Privitera L; Hogg EL; Lopes M; Domingos LB; Gaestel M; Müller J; Wall MJ; Corrêa SAL
    Aging Cell; 2022 Oct; 21(10):e13717. PubMed ID: 36135933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, crystal structure determination, molecular dynamic simulation and MMGBSA calculations of novel p38-alpha MAPK inhibitors for combating Alzheimer's disease.
    Iqbal S; Potharaju R; Naveen S; Lokanath NK; Mohanakrishnan AK; Gunasekaran K
    J Biomol Struct Dyn; 2022 Aug; 40(13):6114-6127. PubMed ID: 33522434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
    Lauretti E; Li JG; Di Meco A; Praticò D
    Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.